- 600 workers reach labor deal with Kaiser
- Vanderbilt Health president, CEO to retire
- Stryker cyberattack tied to Iran: 10 updates
- Hospital margins take a dive
- Hospital margins take a dive
- 3 healthcare roles bucking hiring trends for younger workers
- Data breach at NYC Health + Hospitals partner exposes info of 5,086 patients
- MSU Health Care’s CMO on the biggest barrier to sustained quality improvement
- WellSpan Health launches AI-powered robotic kitchen
- 1 in 3 Americans make financial trade-offs to afford healthcare: Gallup
- How 3 ASC giants stacked up financially in 2025
- UAB neurology telehealth startup expands
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Healthcare worker burnout, anxiety widespread, GAO finds
- Utah passes bill expanding hygienists’ ability to practice without dentist supervision
- Medicare Advantage spending 14% higher than fee for service: Report
- Virginia weighs spending cap on Medicaid dental services to resolve budget shortfall: 5 notes
- Washington hospital to close pediatric rehab clinic
- Good news for anesthesia, pain medicine
- 2 Illinois individuals charged with practicing unlicensed dentistry
- New Jersey system partners with health center ahead of ED closure
- 5 trends that will define the next era of ASCs
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Orthopedic surgeons open Maryland ASC
- Dr. Deborah Brown to lead dental therapy program at Ferris State University
- ASCs’ implant cost problem
- Virginia grapples with dental assistant shortage after training program pauses enrollment
- Imagen Dental Partners adds Arizona practice
- 5 new things to know about the No Surprises Act: GAO report
- New Jersey dental practice opens 8th location
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Intermountain Health opens ambulatory endoscopy center
- Orlando Health breaks ground on bariatric surgery institute
- Universal Health Services moves to acquire physician group
- California allots additional $1B for behavioral health facilities
- How dentistry can get ahead of the next big workforce challenge
- Judge rules Erlanger’s Stark law, fraud cases can proceed: 10 things to know
- Oregon lawmakers greenlight $44M lifeline for hospital
- Florida Senate vote dissolves hospital board
- Federal bill introduced to uphold state dental payer laws
- Mass General Brigham receives $50M for cancer research
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- How Bronson Healthcare increased financial assistance, Medicaid applications
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Genetic Test May Predict Leukemia Relapse Risk
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- 5 state behavioral health policy updates
- Microsoft unveils Copilot Health as an AI health companion for consumers
- Medicare beneficiaries may pay more amid insurer acquisitions of PBMs: Study
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Guidelight names chief growth officer
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Nebraska Medicine’s $99.3M center to expand behavioral health services
- FDA approves 1st treatment for cerebral folate deficiency tied to autistic features
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Colorado hospitals, advocates launch youth mental health coalition
- Climate warming could increase anxiety, depression: Study
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Only 4 states satisfy over 50% of mental health workforce needs: Report
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Chile Becomes First Country in the Americas To Eliminate Leprosy
- Going Abroad? CDC Warns Travelers About Polio Risk in Several Countries
- Listen to the Latest ‘KFF Health News Minute’
- The Fierce Healthcare team on the Fierce 15 of 2026
- Más niños llegan a salas de emergencias con dolor de muelas. Los recortes de Trump y la lucha anti flúor de RFK Jr. no ayudan
- Centene's stock falls as CEO London outlines ongoing ACA headwinds
- AI-fueled misdiagnoses, rural care barriers are 2026's top patient safety threats: ECRI
- Patients want price transparency, e-commerce experience from pharma DTP platforms: survey
- Carrum Health teams up with Virta Health on a comprehensive weight loss solution
- Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
- Novo Nordisk's US headquarters under fire in latest FDA warning letter
- Filana leaves Cassava roots behind amid branch into epilepsy
- Nearly Half of U.S. Kids Lack Adequate Sleep, Survey Shows
- Trump Caused Immediate Decrease in Acetaminophen Rx's For Pregnant Women, Study Finds
- Students Spend A Third Of Their School Day On Their Smartphone, Study Says
- Daily Multivitamins Slow Aging, Clinical Trial Finds
- Stress of Pregnancy Complications Might Impact Future Heart Health, Study Says
- Approved IV Drug, Gazvya, Reduces Lupus Symptoms, Clinical Trial Finds
- CSL telegraphs 300 new hires as it breaks ground on $1.5B plasma-based medicine plant near Chicago
- More Kids Are in ERs for Tooth Pain. Trump Cuts and RFK Jr.’s Anti-Fluoride Fight Aren’t Helping.
- Banks Are Becoming Bulwarks Against Scams for Vulnerable Seniors
- FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
- BioNTech's CEO, CMO prep departure to set up next-gen mRNA company
- HIMSS26: Samsung, b.well partner to 'kill the clipboard,' aligning with a key CMS goal
- HIMSS26: Epic expands AI roadmap, previews Factory to build and orchestrate AI agents
- A $21M farewell: Emma Walmsley lands nearly 50% pay hike in final year as GSK chief
- Remarks at the 45th Annual Small Business Forum
- Founders, Funders, and Forty-Five Forums: Remarks at the 45th Annual Small Business Forum
- Remarks at the 45th Annual Small Business Forum
- Leapfrog ordered to remove safety grades for 5 Tenet hospitals
- FDA unveils 4th revision of draft guidance for looser biosimilar testing requirements
- 'Fibermaxxing' Trend Encourages People To Eat More Fiber
- That Stressful Person in Your Life Might Be Aging You Faster, Study Finds
- Infant Bath Seats Sold on Amazon Recalled Due To Tipping Hazard
The Doctor Patient Forum is requesting public support for FDA regulation of NarxCare by May 10, 2025. They explain and link the FDA comment page in their YouTube video (2 min):
Flagged. Medically Abandoned. Forgotten. Unveiling NarxCare: The Hidden Scoring System in Your EHR.
Unfortunately, DPF's assumption of big government to the rescue fails the logic test. Federal regulation to solve state overreach is a non-starter, but there is a better way.
The State of Michigan directly added the Michigan Automated Prescription System (MAPS) into the electronic health records (EHRs) and pharmacy management systems of hospitals, physician groups and pharmacies across the state in 2017, according to owner Appriss press release and State of Michigan sources. Lt. Gov. Brian Calley signed the enabling bill into law.
That MAPS package included NarxCare.
It is administered by LARA, but don't forget - it began with state legislators, and can only end the same way.
Both parties in Lansing have been operating on the progressive philosophy that "When the government knows and controls, we have better health." Nothing could be further from the truth, as we ought to have learned from COVID.
However, the Doctor Patient Forum's strength is understanding patient impact of status quo Michigan law, and public awareness is the best way to correct law.
I highly recommend their insights into state prescription drug tracing and patient pain control.
https://www.painnewsnetwork.org/stories/2018/5/19/what-every-patient-should-know-about-narxcare
What Every Patient Should Know About NarxCare
May 19, 2018
Walmart and Sam’s Club recently announced that by the end of August their pharmacists will start using NarxCare, a prescription tracking tool that analyzes real-time data about opioids and other controlled substances from Prescription Drug Monitoring Programs (PDMP’s).
Recent studies question the value of PDMP’s, but 49 states have implemented them so that physicians, pharmacists and insurers can see a patient's medication history. Granted, there is a need for monitoring the select few who doctor shop and/or abuse their medications, albeit that number is only in the 2 percent range.
What is NarxCare? Appriss Health developed NarxCare as a “robust analytics tool” to help “care teams” (doctors, pharmacists, etc.) identify patients with substance use disorders. Each patient is evaluated and given a “risk score” based on their prescription drug history. According to Appriss, a patient is much more willing to discuss their substance abuse issues once they are red flagged as a possible abuser.
“NarxCare automatically analyzes PDMP data and a patient’s health history and provides patient risk scores and an interactive visualization of usage patterns to help identify potential risk factors,” the company says on its website.
“NarxCare aids care teams in clinical decision making, provides support to help prevent or manage substance use disorder, and empowers states with the comprehensive platform they need to take to the next step in the battle against prescription drug addiction."
Sounds great doesn't it? Except prescription drugs are not the problem and never really have been. Illicit drug use has, is, and will continue to be the main cause of the addiction and overdose crisis.
Even the name NarxCare has a negative connotation. “Narx” stands for narcotics. And in today's environment, narcotics is a very negative word. NarxCare makes me feel like a narcotics police officer is just around the corner.
Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history.
Ohio, Michigan, Indiana, Iowa, and several other states are using NarxCare to supplement their own PDMPs. And Walmart isn’t the only big retail company to adopt it. Kroger, Ralphs, Kmart, CVS, Rite Aid and Walgreens are already using NarxCare. There’s a good chance your prescriptions are already being tracked by NarxCare and you don’t even know it.
But NarxCare doesn’t just analyze opioid prescriptions. It also tracks other controlled substances, such as antidepressants, sedatives and stimulants. If a patient is on any combination of those drugs, their risk scores and their chances of being red flagged will be higher – even if they’ve been safely taking the medications for years.
There are several other ways a patient can be red flagged, such as having multiple doctors or pharmacies. But what if you moved and changed physicians? What if you had the same physician for many years and he/she retired or moved away? What if your pharmacy refused to fill your prescription and you had to go pharmacy hunting every month? What if you had dental surgery and your dentist placed you on a short-term pain medication?
Unfortunately, the NarxCare scores do not reflect any of that. How can raw data on prescription medications be an indicator of abuse? I believe there is some merit in tracking and weeding out the rare abuser, but NarxCare doesn't factor in all the “what if’s” that can happen to law-abiding and responsible patients.
As pain patients, we need to be acutely aware of the negative impact this analytics tool can have. Many of us have already been required to sign pain contracts, take drugs tests, and undergo pill counts. In 2019, Medicare will adopt policies making it even harder for patients to get high doses of opioid medication. Some insurers are already doing it. We're already being policed enough as it is.
I intend to ask my physician, pharmacist and case manager if they utilize NarxCare. So should you. If they say yes, ask them why. Ask your doctor if they believe you are at risk for substance use disorder. Why is their judgement and treatment of you being second guessed by anyone?
Rochelle Odell lives in California. She’s lived for nearly 25 years with Complex Regional Pain Syndrome (CRPS/RSD).
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













